Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:SMA
CUSIP87154620
WebN/A
Phone+1-574-2682252
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
Symmetry Medical (NYSE:SMA) Frequently Asked Questions
What is Symmetry Medical's stock symbol?
Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."
How were Symmetry Medical's earnings last quarter?
Symmetry Medical Inc. (NYSE:SMA) released its quarterly earnings data on Thursday, October, 30th. The healthcare company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.02. The healthcare company earned $95.90 million during the quarter, compared to analyst estimates of $98.24 million. The firm's revenue was up .2% on a year-over-year basis. During the same period last year, the firm posted $0.08 EPS. View Symmetry Medical's Earnings History.
Who are Symmetry Medical's key executives?
Symmetry Medical's management team includes the folowing people:
- Thomas W. Barrett, Senior Vice President and Chief Commercial Officer - OEM Solutions
- Christopher G. Cummins, Senior Vice President, Chief Manufacturing Officer - OEM Solutions (Age 44)
- Stephen Hinora Jr., Senior Vice President - Quality Assurance/Regulatory Affairs (Age 53)
Has Symmetry Medical been receiving favorable news coverage?
Press coverage about SMA stock has been trending positive recently, according to Accern. The research firm identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Symmetry Medical earned a media and rumor sentiment score of 0.32 on Accern's scale. They also gave news headlines about the healthcare company an impact score of 42.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Symmetry Medical.
How do I buy shares of Symmetry Medical?
Shares of SMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Symmetry Medical's stock price today?
One share of SMA stock can currently be purchased for approximately $13,400.00.
How can I contact Symmetry Medical?
Symmetry Medical's mailing address is 3724 N STATE ROAD 15, WARSAW, IN 46582, United States. The healthcare company can be reached via phone at +1-574-2682252.
MarketBeat Community Rating for Symmetry Medical (NYSE SMA)
MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe SMA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SMA will underperform the S&P 500 over the long term. You may vote once every thirty days.
